US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 18.830
  • +0.920+5.14%
Close Nov 29 13:00 ET
  • 18.085
  • -0.745-3.96%
Post 17:01 ET
478.56MMarket Cap-407P/E (TTM)

About Cartesian Therapeutics Company

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Company Profile

SymbolRNAC
Company NameCartesian Therapeutics
Listing DateJun 22, 2016
CEODr. Carsten Brunn, PhD
MarketNASDAQ
Employees38
Fiscal Year Ends12-31
Address704 Quince Orchard Road
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Phone1-617-923-1400
Websitehttp://www.cartesiantherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carsten Brunn, PhD
  • Director, President and Chief Executive Officer
  • 6.11M
  • Blaine Davis
  • Chief Financial Officer and Principal Accounting Officer
  • 2.49M
  • Dr. Milos Miljkovic, M.D.
  • Chief Medical Officer
  • --
  • Dr. Christopher M. Jewell, PhD
  • Chief Scientific Officer
  • 53.10K
  • Dr. Metin Kurtoglu, M.D.,PhD
  • Chief Technology Officer
  • 5.37K
  • Dr. Emily English, PhD
  • Senior Vice President and Head of Manufacturing
  • --
  • Carrie S. Cox
  • Chairman of the Board
  • 292.32K
  • Dr. Kemal Malik, M.B.B.S.
  • Director
  • --
  • Dr. Timothy A. Springer, M.D.,PhD
  • Director
  • 192.73K
  • Dr. Nishan de Silva, M.B.A.,M.D.
  • Independent Director
  • 188.58K
  • Timothy C. Barabe
  • Independent Director
  • 212.93K
  • Dr. Michael Singer, M.D.,PhD
  • Independent Director
  • 5.71K
  • Dr. Murat Kalayoglu, M.D.,PhD
  • Independent Director
  • --
  • Patrick J. Zenner
  • Independent Director
  • 192.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data